BriaCell Therapeutics Corp. (BCTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

BriaCell Therapeutics Cor...

NASDAQ: BCTX · Real-Time Price · USD
7.87
0.16 (2.01%)
At close: Sep 05, 2025, 3:59 PM
7.90
0.45%
After-hours: Sep 05, 2025, 07:42 PM EDT

BriaCell Therapeutics Income Statement

Financials in CAD. Fiscal year is August - July.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
114.04K 20.49K 19.39K 19.44K
Gross Profit
-114.04K -20.49K -19.39K -19.44K
Operating Income
-46.02K -23.27M -15.29M -6.97M
Interest Income
391.49K 891.21K 136.73K 4.01K
Pretax Income
-6.81K -20.3M -26.84M -13.82M
Net Income
-6.62K -20.3M -11.58M -2.9M
Selling & General & Admin
9.18K 7.94M 7.27M 6.18K
Research & Development
37.53K 15.34M 10.27K 2.02M
Other Expenses
-685 -763 -396 -1.33M
Operating Expenses
46.02K 23.27M 19.58K 6.97M
Interest Expense
n/a n/a 979.00 46.09K
Selling & Marketing Expenses
685.30 n/a n/a n/a
Cost & Expenses
46.02K 23.27M 15.29M 6.97M
Income Tax Expense
n/a -153K 30.73K 6.58M
Shares Outstanding (Basic)
1.1M 1.04M 1.03M 301.31K
Shares Outstanding (Diluted)
1.1M 1.04M 1.03M 301.31K
EPS (Basic)
-4.28 -19.79 -25.7 -46.73
EPS (Diluted)
-4.28 -19.79 -25.7 -46.73
EBITDA
-45.91K -22.37M -34.05M -6.95M
EBIT
-46.02K -27.24M -34.07M -8.71K
Depreciation & Amortization
115.84 15.27K 15.27K 15.26K